Related Experiment Video
Updated: Feb 16, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Hepatic Dysfunction Caused by Consumption of a High-Fat Diet
Anthony R Soltis1, Norman J Kennedy2, Xiaofeng Xin1
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
High-fat diets induce liver dysfunction and inflammation, contributing to insulin resistance and type 2 diabetes. Systems biology reveals disrupted liver architecture and cell death as key early events in metabolic disease development.
Area of Science:
- Molecular biology
- Systems biology
- Metabolic disease research
Background:
- Obesity is a global health crisis linked to insulin resistance and type 2 diabetes.
- The complex molecular mechanisms underlying these conditions are not fully understood.
Purpose of the Study:
- To comprehensively investigate hepatic responses to high-fat feeding using a systems biology approach.
- To integrate multi-omic data to model molecular changes in diet-induced liver dysfunction.
Main Methods:
- Utilized high-throughput omic methods (epigenomics, transcriptomics, proteomics, metabolomics).
- Applied network modeling to integrate diverse molecular signals from mouse liver.
- Validated model predictions through experimental analysis of mouse liver sections.
Main Results:
- Identified disrupted hepatic architecture and enhanced hepatocyte apoptosis as critical early processes.
- Revealed molecular features contributing to liver dysfunction and inflammation.
- Demonstrated the link between these changes and the development of metabolic syndrome.
Conclusions:
- Integrative systems biology provides crucial insights into diet-induced hepatic insulin resistance.
- Understanding these molecular features is key to addressing metabolic disease.
- The study uncovers mechanisms promoting the development and maintenance of metabolic disease.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

